Cardinal Capital Management Increases Stock Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

Cardinal Capital Management raised its holdings in Henry Schein, Inc. (NASDAQ:HSIC) by 6.4% in the third quarter, according to the company in its most recent disclosure with the SEC. The fund owned 14,202 shares of the company’s stock after buying an additional 857 shares during the quarter. Cardinal Capital Management’s holdings in Henry Schein were worth $1,035,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Summit Securities Group LLC purchased a new position in shares of Henry Schein in the 2nd quarter valued at approximately $31,000. Beach Investment Counsel Inc. PA purchased a new position in shares of Henry Schein in the second quarter worth $37,000. Blue Trust Inc. lifted its stake in shares of Henry Schein by 104.2% during the second quarter. Blue Trust Inc. now owns 931 shares of the company’s stock worth $60,000 after buying an additional 475 shares during the period. Mather Group LLC. acquired a new position in shares of Henry Schein in the 1st quarter valued at $97,000. Finally, Livforsakringsbolaget Skandia Omsesidigt lifted its position in Henry Schein by 282.1% during the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,490 shares of the company’s stock worth $109,000 after acquiring an additional 1,100 shares during the period. Institutional investors and hedge funds own 96.62% of the company’s stock.

Analyst Upgrades and Downgrades

HSIC has been the subject of several research analyst reports. Robert W. Baird reduced their price objective on Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a research note on Wednesday, August 7th. UBS Group reduced their price target on shares of Henry Schein from $75.00 to $72.00 and set a “neutral” rating for the company in a research report on Wednesday, August 7th. Piper Sandler reaffirmed an “overweight” rating and issued a $86.00 price objective on shares of Henry Schein in a report on Friday, June 21st. JPMorgan Chase & Co. reduced their target price on shares of Henry Schein from $88.00 to $80.00 and set an “overweight” rating for the company in a report on Monday, August 12th. Finally, Evercore ISI upped their price target on shares of Henry Schein from $70.00 to $74.00 and gave the company an “in-line” rating in a report on Tuesday, October 8th. One analyst has rated the stock with a sell rating, six have assigned a hold rating, five have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the company has an average rating of “Hold” and a consensus price target of $77.50.

Insider Buying and Selling

In other news, SVP Lorelei Mcglynn sold 21,035 shares of Henry Schein stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $69.30, for a total value of $1,457,725.50. Following the sale, the senior vice president now directly owns 71,833 shares of the company’s stock, valued at $4,978,026.90. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. 1.14% of the stock is currently owned by insiders.

Henry Schein Stock Up 1.0 %

Henry Schein stock opened at $72.39 on Friday. Henry Schein, Inc. has a 12 month low of $60.01 and a 12 month high of $82.63. The stock has a market capitalization of $9.27 billion, a PE ratio of 24.46, a price-to-earnings-growth ratio of 1.98 and a beta of 0.86. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.55 and a quick ratio of 0.90. The business has a 50 day simple moving average of $70.33 and a 200-day simple moving average of $69.91.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings data on Tuesday, August 6th. The company reported $1.23 earnings per share for the quarter, topping analysts’ consensus estimates of $1.22 by $0.01. Henry Schein had a net margin of 2.82% and a return on equity of 13.19%. The company had revenue of $3.10 billion during the quarter, compared to analysts’ expectations of $3.27 billion. During the same period in the prior year, the business posted $1.31 earnings per share. The firm’s revenue for the quarter was up .0% on a year-over-year basis. On average, analysts anticipate that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.